Subsequently, we explored the potential involvement of ITLN1 in the IFNγ-mediated suppression of HCC proliferation, a phenomenon observed in HCC and several other tumors [[28], [29], [30], [31]]. The gene discussed is ITLN1; the disease is hepatocellular carcinoma.